Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1437 results
Galena Biopharma inks licensing deal with MonoSol Rx for US rights of Zuplenz
By PBR Staff Writer
US-based biopharmaceutical firm Galena Biopharma has entered into a definitive agreement to license the US rights for Zuplenz (ondansetron) oral soluble film (OSF), from MonoSol Rx, the developer of the oral soluble film technology, PharmFilm, and manufacturer of the product.
Automation > IT & Software > News
Alnylam gets notice of allowance from USPTO for new patent broadly covering conjugate-based delivery of RNA Therapeutics
Alnylam Pharmaceuticals, a leading RNAi therapeutics company, has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the Manoharan et al. patent application 13/693,478.
Automation > IT & Software > News
Harvard Medical School, Phelan-McDermid Syndrome Foundation Contract leverages the tranSMART open-source knowledge management platform
The tranSMART Foundation has announced that the Phelan-McDermid Syndrome Foundation and the Center of Biomedical Informatics at Harvard Medical School were awarded a nearly $1 million contract from the Patient-Centered Outcomes Research Institute (PCORI) to undertake an exciting research endeavor that will leverage the tranSMART platform.
Automation > IT & Software > News
MorphoSys gets additional patents on Ylanthia in US and first patent in China
MorphoSys has announced that the US Patent and Trademark Office (USPTO) and the State Intellectual Property Office of China have granted additional patents covering the Company's latest antibody platform Ylanthia.
Automation > IT & Software > News
Agile Therapeutics announces allowance of additional patent claims for Skinfusion
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for additional patent claims covering dosing regimens using the Company's lead product candidate Twirla (ethinyl estradiol and levonorgestrel transdermal system (AG200-15)), currently in Phase 3 development.
Automation > IT & Software > News
Integral Molecular announces patent allowance for dengue research technology
Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs).
Automation > IT & Software > News
Adynxx begins Phase II trial of AYX1 for prevention of post-surgical pain
By PBR Staff Writer
US-based pharmaceutical firm Adynxx has dosed first patient in a Phase II dose-ranging trial (ADYX-003) of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
Automation > IT & Software > News
Celsion announces commercialization of reagent products
Celsion Corporation, a leading oncology drug development company, has announced initiation of sales of its proprietary reagent products for life science research.
Automation > IT & Software > News
Genmab to receive milestone payment in DuoBody platform collaboration with Janssen
Genmab announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech (Janssen), triggering a $3 million milestone payment.
Automation > IT & Software > News
Codexis, GSK enter into technology collaboration, license agreement
By PBR Staff Writer
Codexis, a US-based developer of biocatalysts for the pharmaceutical and fine chemical industries, has signed a platform technology license agreement with British drug-maker GlaxoSmithKline (GSK).
Automation > IT & Software > News
ProMetic to commercially launch Fibrinogen in Q4 2014
ProMetic Life Sciences has announced that it will launch fibrinogen for commercial sales during the fourth quarter of 2014 after its successful scale-up at its Laval based plasma purification facility, ProMetic BioProduction Inc. (PBP).
Automation > IT & Software > News
Nuvilex scheduled to begin preclinical studies in early August
Nuvilex, a clinical-stage international biotechnology company, has announced that all preparations for the commencement of its preclinical studies to determine the effectiveness of Nuvilex's pancreatic cancer treatment in slowing down the accumulation of ascites fluid have been completed.
Automation > IT & Software > News
Sirnaomics strengthens IP position for advancing novel siRNA therapeutics programs
Sirnaomics has received an Issue Notification from United States Patent and Trademark Office (USPTO) for a patent entitled "Multi-Targeted RNAi Therapeutics for Scarless Wound Healing of Skin" (US 8,735,567 B2, PCT/US2008/012498).
Automation > IT & Software > News
Iroko Pharmaceuticals announces first international filing for ZORVOLEX
Iroko Pharmaceuticals, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the company affiliate’s first regulatory submission outside of the United States for ZORVOLEX (diclofenac) capsules.
Automation > IT & Software > News
CliniWorks, Pfizer to develop population health management platform
CliniWorks has announced a strategic alliance between its I subsidiary CliniWorks (Israel) (CliniWorks Israel) and Pfizer to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health.
Automation > IT & Software > News
76-90 of 1437 results